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Abstract This study aimed to elucidate the effect of electroacupuncture treatment on preventing early ovarian hyperstimulation
syndrome (OHSS) and the potential mechanisms involved using an induced rat model. The ovarian response was examined by mea-
suring ovary weight, vascular permeability, levels of inﬂammation (interleukin-6), tumour necrosis factor alpha, chemokine ligand
2 (also known as monocyte chemoactic protein 1), vascular endothelial growth factor and hormone concentrations (oestradiol, pro-
gesterone, testosterone and prolactin). Sprague–Dawley female rats underwent ovarian stimulation to induce OHSS. Hyperstimulated
rats received consecutive electroacupuncture treatment from 3 days before the beginning of pregnant mare serum gonadotrophin
treatment or the time point of pregnant mare serum gonadotrophin treatment respectively, and last until 3 days after HCG admin-
istration. Electroacupuncture treatment reduced ovary weight and vascular permeability in hyperstimulated rats. Electroacupuncture
treatment also reduced the levels of serum steroid hormones (progesterone and testosterone), inﬂammatory cytokines (interleukin-
6, tumour necrosis factor alpha and monocyte chemotactic protein 1 and vascular endothelial growth factor in hyperstimulated rats.
The results indicate that electroacupuncture can modulate endocrine hormone secretion and affect the secretion of inﬂammatory
cytokines and vascular endothelial growth factor, and thus prevent the progress of OHSS. Electroacupuncture may provide a simple
and effective method for the prevention and treatment of OHSS.
© 2016 The Authors. Published by Elsevier Ltd on behalf of Reproductive Healthcare Ltd. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Ovarian hyperstimulation syndrome (OHSS) is a common iat-
rogenic complication of ovarian stimulation, occurring in about
0.3–5% of cycles (Schenker and Weinstein, 1978). The severe
form of OHSS may cause death. The cause of OHSS remains
elusive. Vascular endothelial growth factor (VEGF) is consid-
ered to be a prime causative agent in OHSS progression
(Abramov et al., 1997). A recent study showed that inﬂam-
matory cytokines such as interleukin (IL)-2, IL-6 and tumour
necrosis factor alpha (TNF-α) are the potential mediators in
the pathogenesis of OHSS (Artini et al., 2002). Multiple
methods have been used to prevent progression of OHSS, which
include cycle cancellation, coasting, intravenous albumin in-
fusion during oocyte collection, low doses of HCG for oocyte
triggering, replacing HCG with a gonadotrophin releasing
hormone agonist to induce ﬁnal follicular maturation, elec-
tive cryopreservation of all embryos, and the administra-
tion of cabergoline (Fatemi and Garcia-Velasco, 2015; Mathur
et al., 2007). The simple, effective and optimal strategy to
prevent OHSS during fresh embryo transfer has not yet been
deﬁned.
Acupuncture is a conventional technique in Traditional
Chinese Medicine. Because of its few side-effects, conve-
nience and unique effect on general wellbeing, acupunc-
ture has gained signiﬁcant popularity in Western countries.
In reproduction, electroacupuncture has shown some advan-
tages in treating polycystic ovary syndrome through multi-
channel and multi-targeted regulation of the reproductive and
endocrine functions in the hypothalamic–pituitary–ovarian
axis. Electroacupuncture can adjust woman’s ovulation and
menstrual cycle by affecting or improving hypothalamus, pi-
tuitary and ovarian functions (Jedel et al., 2011; Manneras
et al., 2009). In addition, evidence is growing that acupunc-
ture can reduce the stress during IVF and embryo transfer,
and improve the success rate (de Lacey et al., 2009; Kovarova
et al., 2010). The ﬁrst clinical trial was published in 1999
(Stener-Victorin et al., 1999), and suggested that acupunc-
ture was effective in improving the clinical pregnancy rate
of IVF.
Our previous unpublished study investigated the effect of
acupuncture on endometrial receptivity. Ovarian volume was
signiﬁcantly smaller and the ascetic ﬂuid was signiﬁcantly de-
creased, compared with those in the control group. These in-
teresting results imply that acupuncture might possess the
potential to prevent the progress of OHSS. The aim of the
present study, was to investigate the effect of different acu-
puncture methods on OHSS rat model, which provides valu-




Immature female Sprague–Dawley rats aged 22 days (D22),
weighing 80–90 g, were obtained from the Animal Experi-
ment Center of Nanjing Jinling Hospital. They were kept under
a controlled 12:12 h light–dark cycle, with standard diet and
free access to water. The study protocol was approved by the
Committee of the Use and Care of Animals of Nanjing Jinling
Hospital on 29 July 2014 (reference number 20140729).
A total of 28 rats were randomly assigned to four groups.
Control group: rats (n = 7) were injected with 10 IU of preg-
nant mare serum gonadotrophin (PMSG) at 15:00 of day 27
(D27) and 10 IU of HCG after 48 h (15: 00 on D29). OHSS group:
the experimental OHSS models were established following
Kitajima et al.’s protocol (2004). Rats (n = 7) received ex-
cessive doses of PMSG (50 IU/day) for 4 consecutive days (from
D25 to D28, at 15:00), followed by 150 IU of HCG (D29, at
15:00). Electroacupuncture pretreatment plus OHSS (PEAO)
group: rats (n = 7) received electroacupuncture treatment for
15 min per day (beginning at 12:00) for 3 days before the OHSS
model was established and continued to D31.
Electroacupuncture plus OHSS (EAO) group: hyperstimulated
rats (n = 7) received acupuncture treatment for 15 min/day
(beginning at 12:00) from D25 to D31.
Electroacupuncture stimulation
All animals were anaesthetized with ketamine. Then, in the
PEAO and EAO groups, electroacupuncture stimulation was
applied to the acupuncture points of unilateral Sanyinjiao (SP6)
and Guanyuan (CV4) by using an electroacupuncture stimu-
lator instrument (Model KDZ-I; Yangzhou Kaida Medical Equip-
ment Co., LTD, Yangzhou, China). In the control and OHSS
groups, the rats were not treated with electroacupuncture.
The depth and location of electroacupuncture were deter-
mined according to the concept of Traditional Chinese Medi-
cine, the atlas of skeleton and acupoints of rat, and the
anatomical location described in previous a study (Hua et al.,
1991). SP6 is situated about 10 mm above the top of the medial
malleolus and on the posterior border of the tibia. CV4 is
located at the point of 3/5 down the ventral midline con-
necting the umbilicus to the pubic tubercle. Two 0.3-mm stain-
less steel acupuncture needles (Shanghai Taicheng Technology
Development Co., LTD, Shanghai, China) that were con-
nected with the output terminal were inserted at a depth of
2 mm into the above-mentioned acupuncture points. The
stimulation with 2 or 15 Hz frequencies was generated at an
intensity of muscle twitch threshold and lasted 15 min every
day.
Measurement of peritoneal and ovarian capillary
permeability
On the basis of Ujioka1’s protocol (1997), all rats (D31) were
anaesthetized with 100 mg/kg ketamine and then kept on a
thermal blanket to avoid hypothermia. A total of 0.2 ml of
5 mmol/l of Evans Blue dye (Sigma, USA, dissolved in dis-
tilled water) was injected via the tail vein. Thirty minutes after
Evans Blue injection, the peritoneal cavity was injected with
5 ml of 0.9% saline (21°C, pH 6.0) and massaged for 30 s. Sub-
sequently, to prevent tissue or vessel damage, the ﬂuid was
drained through an insemination catheter (Cook Medical Trade
Co., LTD, Shanghai, China). The peritoneal ﬂuid was recov-
ered in tubes containing 0.05 ml of 0.1 mol/l sodium hydrox-
ide to avoid any protein interference. After centrifugation at
900 × g for 15 min at room temperature, Evans Blue
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concentration was measured at 620 nm on a spectrophotom-
eter (Synergy HTX, BioTek Instrument, Inc. USA).
Ovaries were collected after blood collection. Two ovaries
from each rat were weighed; the right one was frozen at
−80°C, and the left one was incubated in 2 ml formamide at
37°C for 24 h. To evaluate the capillary permeability in the
ovary, Evans Blue concentration in the formamide extract of
the ovary was also measured. The dye concentration in the
peritoneal irrigated ﬂuid was presented as μg/100 g body
weight, and Evans Blue content in the ovary was presented
as μg/g tissue wet weight.
Hormone assays
After peritoneal irrigation, blood samples were immedi-
ately collected from orbital puncture. Blood samples were kept
at room temperature for 10 min and then centrifuged at 900 g
for 10 min. The serum was collected and stored at −80°C until
assay. The levels of progesterone, oestradiol, testosterone,
and prolactin were determined by chemiluminescent immu-
noassay system (Backman Coulter, Inc., Brea CA, USA). The
intra-assay and inter-assay coefﬁcients of variation for pro-
gesterone, oestradiol, testosterone and prolactin were 8.18
and 7.89%, 5.13 and 6.23%, 2.56 and 5.19%, and 5.52 and
3.53%, respectively.
Measurements of VEGF, TNF-α, IL-6 and MCP-1
Ovaries in ice-cold phosphate buffered saline (0.01 mol/l, pH
7.0–7.2) were homogenized with ultrasonic cell crusher
(SONICE, USA). Supernatant was obtained by centrifugation
at 12,000 g for 30 min. Protein concentration was deter-
mined by the bicinchoninic acid method. Serum interleukin
6 (IL-6), tumour necrosis factor alpha (TNF-α) and mono-
cyte chemoactic protein 1 (MCP-1) levels were determined
by enzyme-linked immunosorbent assay (ELISA). The VEGF and
IL-6 levels in the ovary extract were determined by ELISA. The
Kits for VEGF, IL-6, TNF-α and MCP-1 were purchased from
Sigma (St Louis, MO, USA, for VEGF of ovary, IL-6, TNF-α and
MCP-1 of serum), Cloud-Clone Co. (Houston, TX, USA, for IL-6
of ovary). The measurement range of serum TNF-α, MCP-1 and
IL-6 ELISA kits was 82.30–20000 pg/ml, 24.67–18000 pg/ml and
40.96–10000 pg/ml, respectively; and with a sensitivity of
25 pg/ml, 15 pg/ml and 30 pg/ml, respectively. The mea-
surement range of ovarian VEGF and IL-6 ELISA kits was 0.82–
200 pg/ml and 1.56–100 pg/ml, respectively; and with a
sensitivity of 2 pg/ml and 0.55 pg/ml, respectively.
Statistical analysis
Data were presented as mean ± standard error of mean (SEM).
One-way ANOVA method was used for comparisons of means
of normally distributed parameters, and the homogeneity of
variance was tested before (with 0.1 as the standard test con-
ducted Levene test). When equal variances were assumed,
the least signiﬁcant difference test was selected; other-
wise, a Dunnett’s T3 test was carried out. Statistical analy-
ses were conducted with the Statistical Package for the Social
Sciences Version 13.0 (SPSS Inc., Chicago, IL, USA).
Results
Effect of electroacupuncture on ovary enlargement
Ovary weight was signiﬁcantly increased in OHSS, PEAO and
EAO groups (P < 0.01) compared with the control group. Only
PEAO but not EAO signiﬁcantly reduced ovary weight (P < 0.05)
(Figure 1A), compared with the OHSS group.
Measurement of Evans Blue in peritoneal irrigated
ﬂuid and ovarian capillary permeability
Ovarian capillary permeability was assesed using Evans Blue
dye. Compared with the control group, Evans Blue concen-
tration in peritoneal irrigated ﬂuid in the OHSS group was sig-
niﬁcantly increased (P < 0.01) (Figure 1B). Concentration of
Evans Blue was signiﬁcantly decreased by PEAO but not EAO
in peritoneal irrigated ﬂuid (P < 0.05) compared with OHSS
group. Moreover, compared with EAO group, PEAO also ob-
viously reduced Evans Blue concentration (P < 0.05)
(Figure 1B). Compared with control group, Evans Blue dye
content in the ovary was statistically signiﬁcantly higher in
the OHSS group (P < 0.01). In the OHSS group, PEAO caused
a statistically signiﬁcant reduction of ovarian Evans Blue
content (P < 0.05) (Figure 1C).
Effect of electroacupuncture treatment on the
secretion of hormones
Serum oestradiol and prolactin levels in rats experiencing OHSS
were signiﬁcantly higher than those in control rats (P < 0.01),
whereas both PEAO and EAO slightly reduced oestradiol and
prolactin levels in the rats experiencing OHSS, although the
differences were not statistically signiﬁcant (Figure 2A and
2B). Serum progesterone and testosterone levels in rats ex-
periencing OHSS, compared with the control group, were in-
creased 3.5-fold and 2.7-fold, respectively. Compared with
the OHSS group, PEAO but not EAO signiﬁcantly decreased
serum progesterone and testosterone levels (P < 0.05)
(Figure 2C and 2D).
Effect of electroacupuncture treatment on serum
MCP-1 and TNF-α levels and ovarian IL-6 expression
Compared with the control group, levels of MCP-1 and TNF-α
in serum were signiﬁcantly higher in the OHSS group (P < 0.05
and P < 0.01, respectively) (Figure 3A and 3B). PEAO but not
EAO signiﬁcantly decreased levels of MCP-1 and TNF-α levels
in serum, and PEAO also reduced ovarian IL-6 expression com-
pared with OHSS group (P < 0.05) (Figure 3).
Electroacupuncture treatment affects VEGF
expression in the ovary
Compared with the control group, the expression of VEGF in
the ovary was signiﬁcantly higher in the OHSS group (P < 0.01)
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(Figure 4). Compared with the OHSS group, PEAO but not EAO
signiﬁcantly reduced VEGF expression in the ovary (P < 0.05)
(Figure 4).
Discussion
Ujioka et al. (1997) ﬁrst used immature female rats to produce
a hyperstimulated manifestation. In the present study, an ex-
perimental rat model of OHSS based on previous literature
(Kitajima et al., 2004) was established. Brieﬂy, D25 rats were
treated with consecutive 4-day PMSG and induced ovulation
with high-dose of HCG. We found the ovaries in our model were
signiﬁcantly enlarged and showed increased capillary per-
meability. In particular, the local capillary permeability of
ovary was signiﬁcantly increased. Our results showed that the
OHSS rat model in rats was successfully generated.
Acupuncture points are the locations where the needle can
gain access to some deeper tissue components and mostly
convey the impression along the meridians. Particular
acupoints link with unique connective tissue location (Langevin
and Yandow, 2002). In this study, the stimulated points were
Sanyinjiao (SP6) and Guanyuan (CV4). According to the Tra-
ditional Chinese Medicine principles and modern acupunc-
ture point theory, SP6 is considered as a classic acupoint for
female disorders and can soften and harmonize the liver func-
tion and beneﬁt the kidney Qi (Wang, 2003). CV4 is on the
conception vessel, which can nourish the uterus to adjust the
axis function (Wang, 2003). On the basis of a multitude of
documents and materials, the SP6 and CV4 acupoints have
been commonly used to clinically treat a series of diseases
in the Department of Gynaecology in China. Therefore, the
SP6 and CV4 acupoints were used as the experimental treat-
ment choice in this study.
Fresh embryo transfer has been widely used in various re-
productive medical centres, so it is important to prevent OHSS
in clinic. According to our previous data (unpublished), we
hypothesize that electroacupuncture is a potentially useful
treatment to prevent OHSS. The start time, intensity and the
last time of acupuncture, however, should be deﬁned. There-
fore, in the present study, we used two electroacupuncture
methods (PEA and EA). This experimental design would propose
basic research for further clinical application.
Some reports have found that patients who experience
OHSS, and rats induced to achieve OHSS, demonstrate in-
creased expression level of progesterone and testosterone
(Gomez et al., 2006; Ozcakir et al., 2005; Yuen et al., 1979).
These data imply that progesterone and testosterone con-
tribute, at least in part, to the pathophysiology of OHSS. In
our study, PEA showed a non-signiﬁcant tendency to reduce
serum oestradiol and prolactin levels and it signiﬁcantly de-
creased the level of progesterone and testosterone. Chen
(1997) summarized that electroacupuncture might regulate
the dysfunction of hypothalamic–pituitary–ovarian axis in
several ways, in which electroacupuncture could affect some
gene expression in brain, thereby, regulate secretion of some
hormones. Liu et al. (2009) punctured CV4 and SP6 in rats with
primary dysmenorrhoea and observed the elevated serum FSH,
LH and oestradiol levels, and decreased progesterone level.
Jie Sun et al. (2013) observed that androstenedione and tes-
tosterone were signiﬁcantly decreased after 14 consecutive
days of electroacupuncture in rats with polycystic ovary syn-
drome. Combined with our results, acupuncture could at-
tenuate the symptoms of OHSS through down-regulating
progesterone and testosterone expression level.
The association between cytokines and the pathophysiol-
ogy of OHSS is still unclear. Abramov et al. (1996), however,
reported high concentration of cytokines in the ascitic ﬂuid
and plasma of patients with severe OHSS. Friedlander et al.
(1993) observed a high level of IL-6 in plasma and ascitic ﬂuid
of patients experiencing OHSS. Chistyakova et al. (2014)
Figure 1 Effects of electroacupuncture treatment on ovary
weight and capillary permeability in rats induced to achieve
ovarian hyperstimulation syndrome. (A) Comparison of rat ovary
weight between groups; (B) comparison of Evans Blue concen-
tration in peritoneal irrigated ﬂuid; (C) comparison of Evans Blue
concentration in the ovarian extract. Values are expressed as
mean ± SEM. *P < 0.05, **P < 0.01. EB, Evans Blue dye. EAO,
electroacupuncture plus OHSS; OHSS, ovarian hyperstimulation
syndrome; PEAO, electroacupuncture pretreatment plus OHSS.
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reported that the levels of TNF-α and IL-6 were signiﬁcantly
increased in patients with early and late OHSS. Because high
MCP-1 is regarded as an early sign of vascular damage and car-
diovascular disease, high level of MCP-1 in rats induced to
achieve OHSS is associated with vascular damage, which is also
consistent with high capillary permeability in these rats. These
ﬁndings suggest a close relationship between inﬂammatory
cytokines and the pathophysiology of OHSS. Our present study
found that the levels of TNF-α and MCP-1 in serum and of IL-6
in ovary were signiﬁcantly rescued by PEA. It has been re-
ported that testosterone can increase TNF-α and MCP-1 ex-
pression in RAW264.7 macrophage in vitro (Zhu et al., 2009);
testosterone enhances lipopolysaccharide-induced IL-6 and
MCP-1 expression in 3T3-L1 adipocytes (Su et al., 2015). There-
fore, we speculate that acupuncture can down-regulate the
expression level of inﬂammatory factors, such as TNF-α, IL-6
and MCP-1, via reducing the testosterone level, which pre-
vents the progression of OHSS.
It has been reported that the fundamental physiological
change related to OHSS is characterized by increased vascu-
lar permeability, leading to the leakage of ﬂuid from the vas-
cular compartment, with third-space ﬂuid accumulation and
intravascular dehydration (Chen et al., 2012). VEGF, also
known as vascular permeability factor, seems to be the criti-
cal mediator of OHSS by increasing vascular permeability
(Ludwig et al., 1998; Mansour et al., 2005; Nargund et al.,
2007; Rizk et al., 1997).
Gomez et al. (2002) reported a cause–effect relationship
between increased vascular permeability and ovarian VEGF
expression (Gomez et al., 2002). On the basis of indirect ob-
servations in women with enlarged ovaries and ascites,
Itskovitz-Eldor et al. (1997) thought that the ovary may be
the source and target of VEGF in humans. Artini et al. (1998)
showed that the levels of serum and follicular ﬂuid VEGF in
patients with severe OHSS were signiﬁcantly higher than those
among controls. Our data also show that VEGF level in the
ovary of OHSS rats was signiﬁcantly higher than that in the
control group. Moreover, increased VEGF levels in the ovary
were consistent with increased capillary permeability in the
ovary (high Evans Blue concentration) of rats with OHSS. In
this experiment, we found that electroacupuncture pretreat-
ment could reduce ovary weight and capillary permeability
in the peritoneal irrigated ﬂuid and ovary. Moreover,
electroacupuncture pretreatment signiﬁcantly decreased the
production of VEGF from ovary. Wei et al. (2013) showed that
IL-6 trans-signalling can induce vascular leakage and in-
creased the expression of VEGF in OHSS (Wei et al., 2013).
Zhang et al. (2009) observed that TNF-α can induce the human
umbilical vein endothelial cell production of VEGF. This evi-
dence supports the concept that electroacupuncture inhib-
its VEGF expression and reduces vascular permeability, which
is achieved by down-regulating inﬂammatory factors, to reduce
vascular permeability. On the other hand, our present study
also found the expression of progesterone and VEGF was in-
hibited by electroacupuncture. Yuan et al. (2002) found that
progesterone can also regulate the expression of VEGF. So we
speculate that the low expression of VEGF may be affected
by reduced progesterone.
Figure 2 Effects of electroacupuncture on serum levels of (A) oestradiol; (B) prolactin (B); (C) progesterone and (D) testosterone
in rats induced to achieve ovarian hypserstimulation syndrome. The level of four hormones was determined by chemiluminescent
immunoassay. Values are represented as mean ± SEM. *P < 0.05, **P < 0.01. EAO, electroacupuncture plus OHSS; OHSS, ovarian hy-
perstimulation syndrome; PEAO, electroacupuncture pretreatment plus OHSS.
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This study, however, has several limitations. First,
electroacupuncture pretreatment was only for 3 days before
PMSG treatment and lasted for 10 days. Although
electroacupuncture pretreatment exerted signiﬁcant effect
on inhibiting the progression of OHSS, the most appropriate
therapeutic course for OHSS treatment still needs further in-
vestigation. Second, we only chose CV4 and SP6 as acupunc-
ture points. Whether other acupoints have good or even better
effects still needs investigation. Third, the suitable clinical
treatment protocol to prevent OHSS in those patients who have
potential of high-response is still being investigated. We will
observe the effect of PEA on preventing OHSS using random-
ized controlled trials in the future.
In conclusion, our data support that electroacupuncture
can affect testosterone and progesterone expression and down-
regulate the expression of inﬂammatory factors and VEGF,
and thus cause restrained vascular permeability.
Electroacupuncture, especially PEA, in clinical fresh embryo
transfers, may provide a simple and effective treatment
method to prevent the process of OHSS.
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